CEO Insider Buy Signals Omeros’ Oncology Pipeline Momentum & Future Growth
CEO insider buy of Omeros shares signals confidence in the company’s oncology pipeline and future profitability, amid clinical progress and strategic market positioning.
6 minutes to read